New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - aciclovir 250mg - powder for infusion - 250 mg - active: aciclovir 250mg excipient: sodium hydroxide

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - metformin hydrochloride 250mg - coated tablet - 250 mg - active: metformin hydrochloride 250mg excipient: magnesium stearate opadry clear oy-29020 povidone water

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - amoxicillin trihydrate 52.4 mg/ml equivalent to amoxicillin 50 mg/ml (12 mg overage per 5 ml) - powder for oral suspension - 250 mg/5ml - active: amoxicillin trihydrate 52.4 mg/ml equivalent to amoxicillin 50 mg/ml (12 mg overage per 5 ml) excipient: aspartame colloidal silicon dioxide disodium edetate propylene glycol alginate raspberry flavour permaseal 10458-31 sodium benzoate sodium citrate dihydrate sorbitol - treatment of infection: alphamox is indicated in the treatment of infections due to susceptible organisms. alphamox may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to alphamox should be performed.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmbio pty ltd - paracetamol 665mg - modified release tablet - 665 mg - active: paracetamol 665mg excipient: colloidal silicon dioxide ethylcellulose hypromellose instacoat universal white ic-u-1308 magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - osteomol 665 is effective for the relief of persistent pain associated with osteoarthritis and muscle aches and pains such as backache. osteomol 665 also provides effective, temporary relief of pain and discomfort associated with headache, tension headache, period pain, toothache and pain after dental procedures, and cold & flu. reduces fever.

United States - English - NLM (National Library of Medicine)

zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422), ketoprofen (unii: 90y4qc304k) (ketoprofen - unii:90y4qc304k) - draxxin® kp is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis , and control of pyrexia associated with brd in beef steers, beef heifers, beef calves 2 months of age and older, beef bulls, dairy bulls, and replacement dairy heifers. not for use in reproducing animals over one year of age, dairy calves, or veal calves. the use of draxxin kp injection is contraindicated in animals previously found to be hypersensitive to tulathromycin and ketoprofen. not for human use. keep out of reach of children. the safety data sheet (sds) provides more detailed occupational safety information. to obtain a safety data sheet contact zoetis inc. at 1-888-963-8471.

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - choriogonadotropin alfa - injection, solution - 250 mcg - choriogonadotropin alfa 250 mcg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

modern pharmaceutical company serbia - 250 ml glass bottle - infusion - 400 mg/ 250 ml - infections-antibacterial

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - cephalexin 250 mg - 250 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store saudi arabia - 250ml bottle - inhalation - 250 ml - anaesthesia-general anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry brown 03c86943 poloxamer sodium starch glycolate tolpovidone i 131 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for: · prophylaxis of plasmodium falciparum malaria in adults · treatment of plasmodium falciparum malaria in adults.